A 6-4 FDA panel vote could reshape #cancer screening.
We examine GRAIL's Galleri test and what's next for multi-cancer early detection: https://t.co/tV5xvyP7w7
Only 2% of health systems surveyed have deployed #AI enterprise-wide. Mykhailo Hentosh of @Binariks examines why AI #medtech stalls at the pilot stage and what investors should evaluate: https://t.co/irI5LvaSaf
#Medtech M&A reached $40.8B across 52 announced deals in 2026 through Sept. 4. Here's how the acquisitions and technologies driving renewed deal activity across the industry: https://t.co/ReVtvAacyt
90% of kidney disease patients may qualify for home dialysis, yet most receive in-center care. Explore how @VantiveHealth is using digital #innovation to bridge the gap: https://t.co/dKygKinUGi
The next wave of #medtech innovation is heading to Dublin. Will your company be part of it?
Applications are NOW OPEN for Presenting Companies at #InnovationDublin 2027, April 27–29.
Showcase your technology to industry leaders and investors.
Apply: https://t.co/e4Pej5GbfU
"One of the things I've always admired about the medtech community is the willingness of people to share what they know & help others succeed. Few embodied that spirit better than David Cassak." Read more on David's legacy in Andrew Cleeland's CEO column: https://t.co/4GUmFjNht6
Great energy at @MedTechStrat Innovation Summit!
Perimeter CEO, @adrianvmendes, presented in Oncology therapeutic category, sharing our vision for transforming cancer care through AI-enabled, real-time, 3D imaging.
Thanks to everyone who stopped by to chat.
#InnovationSanDiego
Thank you for making #InnovationSanDiego 2026 a success.
We're grateful to our sponsors, speakers, attendees, presenting companies, the MedTech Strategist team, and The US Grant Hotel team.
Next stop: #InnovationDublin 2027, April 27–29 at The Shelbourne Hotel.
Singapore is becoming a global #medtech powerhouse. Up next at #InnovationSanDiego 2026: “Singapore Rising: From Promise to MedTech Powerhouse.” Industry leaders from @LightstoneVC and @FogartyInnov explore Singapore's growing role in medtech innovation, investment, and more.
Risk and reward are reshaping #medtech investment.
Up next at #InnovationSanDiego 2026: “The De-Risking Race: Why Capital Is Moving to Late-Stage Medtech.”
Experts from @ShangbayCapital and MVM Partners explore shifting investment priorities and funding trends.
What's driving the next wave of #medtech deals? Up next at #InnovationSanDiego 2026: “Deals, Dollars & Disruption: Navigating the Medtech M&A and Investment Landscape.” Experts from @RaymondJames, @HSBC, and @ThisIsBTIG discuss evolving investment trends and M&A dynamics.
#AI is reshaping how medical device companies innovate and compete.
Up next at #InnovationSanDiego 2026: “AI as a Strategic Differentiator in Medical Devices.”
Industry leaders from @VektorMedical, Acorai, and Buenavista Equity Partners explore AI's impact on #medtech.
Meaningful connections remain at the heart of #InnovationSanDiego 2026.
As we continue Day 3, attendees are gathering in the Presidential Ballroom Foyer for a networking break.
Now presenting at #InnovationSanDiego 2026: Ruth Medical CEO Adam Marsh showcases an innovative #drugdelivery device designed to simplify treatment for patients with asthma and COPD, making respiratory care more efficient and convenient for everyday life.
Now presenting at #InnovationSanDiego 2026: Ropana Vascular CEO James Lowry showcases FirstPass™, an innovative intravascular lithotripsy catheter designed to navigate heavily calcified arterial blockages and advance treatment options for peripheral artery disease. #medtech
Now presenting at #Innovation26 in San Diego is @brain4care is a pioneering NeuroTech company transforming brain monitoring through its FDA-cleared, noninvasive technology that provides real-time insights into intracranial dynamics.
Now presenting at #InnovationSanDiego 2026: GrOwnValve CEO Boris Schmitt showcases personalized, regenerative heart valve #technology designed for minimally invasive implantation, with the potential to grow with patients and transform heart valve care.
Now presenting at #InnovationSanDiego 2026: EBAMed CEO Marcin Golebicki showcases an #AI-powered cardiac motion management system designed to improve precision during non-invasive cardiac radioablation procedures while protecting surrounding healthy tissue.